The analysis project was launched in 2016 in order to raise the investors' level of knowledge of about TASE listed technology and biomed companies and the markets in which the companies operate, thus creating appropriate pricing and increasing the exposure of investors from Israel and abroad. Its goal is to encourage investments in these companies by removing the barrier of lacking understanding in the market.
In order to maintain professional, independent and unbiased analysis, the companies signed an agreement with the TASE to receive the analysis services for an obligatory period of two years. The companies cannot withdraw from the project during this period. The analysis is funded by the companies surveyed with funding from the Chief Scientist and the TASE.
The Tel-Aviv Stock Exchange (TASE), Edison and Frost & Sullivan have signed an agreement for the analysis of technology and biomed companies listed on TASE. It is part of the recommendations of the Committee for Promotion of Investments in Research and Development traded companies (the "R&D Committee").
The analyses will be published, at least four times a year, following the publication of the companies' financial statements. In addition, updates will be published upon the occurrence of a significant event in a company that requires updating in the latest analytical work. The English analyses are published by the research companies worldwide, through the main information distributors, and large distribution channels.
An international equity research firm with a team of over 100 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to close to 500 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. For further information, please visit: www.edisoninvestmentresearch.co.uk. Edison is authorised and regulated by the Financial Services Authority.
Frost & Sullivan
A leading global consulting, and market & technology research firm that employs a staff of 1,800, which includes analysts, experts, and growth strategy consultants at approximately 50 branches across 6 continents, including in Herzliya Pituach, Israel. Frost & Sullivan will utilize the experience and know-how accumulated over the course of 55 years in medical technologies, life sciences, technology, energy, and other industrial fields, including the publication of tens of thousands of market and technology research reports, and economic analyses and valuations. For additional information on Frost & Sullivan's capabilities, visit: www.frost.com Frost & Sullivan Research and Consulting Ltd., a wholly owned subsidiary of Frost & Sullivan, is registered and licensed in Israel to practice as an investment adviser.
View all the analyses published in the framework of the project:
Frost & Sullivan: https://ww2.frost.com/research/equity-research/